Skip to main content

Find Clinical Trials

Home
Conditions
Local Advanced or Metastatic NSCLC

Clinical trial condition

Local Advanced or Metastatic NSCLC

Explore clinical trials studying Local Advanced or Metastatic NSCLC. Study availability and eligibility vary by location and protocol.

3 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Local Advanced or Metastatic NSCLC trial results

Not Yet Recruiting

Garsorasib In KRAS G12C Mutant Locally Advanced and Metastatic NSCLC

NCT07294261

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Not Yet Recruiting

JMT101 in Combination With Osimertinib, Versus Cisplatin-pemetrexed in Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Characterized by Epithermal Growth Factor Receptor (EGFR) Exon 20ins Mutations

NCT06380348

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Not specified

View Trial Details

Active, Not Recruiting

JMT101 Combined With Osimertinib in Patients With Stage Ⅲb-Ⅳ Non-small Cell Lung Cancer (NSCLC) Characterized by Epithermal Growth Factor Receptor (EGFR) Common Mutations

NCT06391944

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: Li Zhang Beijing, Beijing Municipality, China

View Trial Details